MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


IN BRIEF: Syncona to focus on realisations to return £250 million

ALN

Syncona Ltd - London-based investor in life science companies - Sets out results of its strategy review, proposing focus on realisations of mature private companies in its portfolio until it has been able to return up to £250 million to shareholders ‘in a timely manner’. The returns, representing about 40% of the company’s current market value, could take the form of a tender offer, share buyback, or special dividend, Syncona says.

The portfolio ‘is funded to deliver 10 key value inflection points over the next three years, with the potential to drive significant NAV growth,’ the company says. Syncona Investment Management Ltd, the company’s advisor, will work with portfolio to deliver these inflection points. SIML also aim to raise a new private fund to invest alongside Syncona to diversify funding sources for those portfolio companies.

Once £250 million has been returned to shareholders, Syncona will focus once again on funding new life science investments and existing portfolio companies, it says, aiming for a portfolio of 20 to 25 companies. However, it will no longer seek to grow assets to £5 billion by 2032, as was its previous target.

Current stock price: 99.76 pence for £606.4 million market capitalisation

12-month change: down 8.5%

Copyright 2025 Alliance News Ltd. All Rights Reserved.